Colorectal Cancer Trial, Recruiting NCT07276529 Sponsor: GI Windows, Inc. Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07276529
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 22 years of age or older at the time of screening
  • You are scheduled for a specific type of large bowel (colon) removal surgery, and your doctors have confirmed you are healthy enough to have it
  • You are able to read, understand, and sign a consent form for the study
  • Your overall health and fitness for anesthesia has been assessed as acceptable (below the highest-risk category)
  • If you have had cancer, you finished chemotherapy at least 2 months before the procedure
  • You live within 150 miles of the study center and plan to stay in that area for the whole study
  • You are able to avoid smoking for the entire follow-up period of the study

Who may not be able to join:

  • You have a known or suspected allergy to silicone, nickel, titanium, or a metal called Nitinol
  • Your body mass index (a measure of weight relative to height) is above 55
  • Your diabetes is poorly controlled (confirmed with a specific blood test result)
  • You have a birth defect or other condition affecting your digestive tract that could block a small medical device from passing through
  • You have been recently diagnosed with a blocked or burst (perforated) colon cancer
  • There are medical reasons why you cannot safely have a camera procedure (endoscopy) or keyhole (laparoscopic) surgery, or you have had a failed camera procedure in the past that suggests it would be difficult again
  • You have a history of repeated small bowel blockages
  • You have a blood clotting problem that cannot be managed with medication, or your platelet count (cells that help blood clot) is too low
  • You have moderate to severe kidney disease or are currently on dialysis
  • You have abnormally high potassium levels in your blood, a tendency for blood to clot too easily, or a history of blood clots in your veins or lungs
  • Your immune system is weakened — for example, due to active cancer treatment, a blood cancer, HIV, or taking medicines that suppress the immune system (confirm with trial site)
  • You have significant heart failure or a serious irregular heart rhythm (confirm with trial site)
  • You have severe, uncontrolled chronic lung disease
  • You have an active infection at or near the surgical area, or the wound is classified as heavily contaminated or infected
  • You have a medical reason that means you cannot safely receive general anesthesia
  • You are currently breastfeeding, pregnant, or planning to become pregnant during the study follow-up period
  • You are currently taking part in, or have taken part in, another clinical trial involving an experimental drug, device, or treatment within the last 30 days
  • The lead doctor running the trial does not consider you a suitable candidate for the study for medical reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Erik Wilson, MD, Chief Medical Officer

Phone: 9787610183

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
GI Windows, Inc.
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Successful anastomosis created with the Flexagon SFM plus OTOLoc without reoperation.; Anastomosis success

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov